Google+ Facebook Twitter Twitter

May tech news

Latest tech news for May.

Antigen collab

OXGENE and The Native Antigen Company have announced a collaboration to scale up production of COVID-19 reagents. They will do so by combining OXGENE’s proprietary adenoviral protein machine technology with The Native Antigen Company’s antigen development expertise.

They will aim to scale their antigen manufacturing to deliver proteins for the development of diagnostics and vaccines.


US approval

Promega Corporation’s GoTaq Probe 1-Step RT-qPCR System is now in a Centres for Disease Control and Prevention COVID-19 diagnostic protocol for emergency use.

The Promega tool is an approved master mix option for the CDC’s 2019-Novel Coronavirus Real-Time RT-PCR Diagnostic Panel, available through emergency use authorisation. In a March 30 letter, the FDA granted approval of an amendment to the CDC’s diagnostic COVID-19 assay.


Scientists on Standby portal

BioStrata, a specialist life science marketing agency, has launched Scientists on Standby – a new portal to support the recruitment of qualified scientists and researchers who could volunteer their time and expertise in the sample testing and screening of the coronavirus.

The portal will provide government bodies and diagnostic testing laboratories with a database of UK-based volunteers specialising in reverse transcription-polymerase chain reaction, immunoassays and good laboratory practice, all grouped by location for easy regional allocation.


Download PDF

Related Articles

Biomedical scientists honoured

Two biomedical scientists who are IBMS members were acknowledged in the Queen’s Birthday Honours this year:

IBMS President presents to MPs

IBMS President Allan Wilson gave evidence at a COVID-19 hearing to a select committee of MPs and Members of the Lords in October.

"Trust and inequality fuelling COVID-19 spread"

Trust in public institutions is linked to fewer COVID-19 deaths – however, trust and belonging to groups is associated with more deaths.

Medical eponyms (part 2): Aloysius Alzheimer

This is the second of selected short biographies of persons whose names are directly used for diseases, conditions, syndromes or tests familiar to those working in clinical pathology laboratories.